Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 4, 2018New England Journal of MedicineOpen Access

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

View Full Paper
Ask AI
Bookmark
Share

Authors

KSKeith SullivanEGEllen GoldmuntzLKLynette Keyes-Elstein

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sullivan et al. (2018) studied this question.

synapsesocial.com/papers/69da21d00f778bd2e468427dhttps://doi.org/10.1056/nejmoa1703327
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease2007 · 464 citations
  2. 2Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases2009 · 363 citations
  3. 3Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population2003 · 940 citations
  4. 4Categorical Data Analysis Using the SAS System1996 · 1,879 citations
  5. 5High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study2007 · 264 citations